Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An intervention to improve secondary prevention of coronary heart disease.
Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC. Bailey TC, et al. Among authors: blickensderfer a. Arch Intern Med. 2007 Mar 26;167(6):586-90. doi: 10.1001/archinte.167.6.586. Arch Intern Med. 2007. PMID: 17389290 Clinical Trial.
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.
Gaebler JA, Soto-Campos G, Alperin P, Cohen M, Blickensderfer A, Wintle M, Maggs D, Hoogwerf B, Han J, Pencek R, Peskin B. Gaebler JA, et al. Among authors: blickensderfer a. Vasc Health Risk Manag. 2012;8:255-64. doi: 10.2147/VHRM.S28744. Epub 2012 Apr 23. Vasc Health Risk Manag. 2012. PMID: 22566747 Free PMC article.
Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting.
Bergenstal RM, Garrison LP Jr, Miller LA, Hou L, Blickensderfer A, Zagar A, Stanley S, Bhargava A, Wade R, Herman WH. Bergenstal RM, et al. Among authors: blickensderfer a. Curr Med Res Opin. 2011 Dec;27(12):2335-42. doi: 10.1185/03007995.2011.628305. Epub 2011 Nov 16. Curr Med Res Opin. 2011. PMID: 22085180 Clinical Trial.
Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting.
Bergenstal RM, Garrison LP Jr, Wintle M, Blickensderfer A, Wade R, Hou L, Miller LA, Scism-Bacon J, Zagar A, Misurski D, Herman WH. Bergenstal RM, et al. Among authors: blickensderfer a. Curr Med Res Opin. 2011 Mar;27(3):531-40. doi: 10.1185/03007995.2010.545814. Epub 2011 Jan 10. Curr Med Res Opin. 2011. PMID: 21219119